Treatment of aggressive recurrent meningiomas: spinning towards peptide receptor radionuclide therapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment of aggressive recurrent meningiomas: spinning towards peptide receptor radionuclide therapy
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-12-14
DOI
10.1007/s00259-018-4221-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lung Metastases of Intracranial Atypical Meningioma Diagnosed on Posttherapeutic Imaging After 177Lu-DOTATATE Therapy
- (2018) Philipp Backhaus et al. CLINICAL NUCLEAR MEDICINE
- Correlation of dose with toxicity and tumour response to 90Y- and 177Lu-PRRT provides the basis for optimization through individualized treatment planning
- (2018) Marta Cremonesi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
- (2017) Anna Sundlöv et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation study
- (2017) Michela Del Prete et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Octreotide therapy in meningiomas: in vitro study, clinical correlation, and literature review
- (2017) Thomas Graillon et al. JOURNAL OF NEUROSURGERY
- PET imaging in patients with meningioma—report of the RANO/PET Group
- (2017) Norbert Galldiks et al. NEURO-ONCOLOGY
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- EANO guidelines for the diagnosis and treatment of meningiomas
- (2016) Roland Goldbrunner et al. LANCET ONCOLOGY
- 68Gallium-DOTATATE PET in meningioma: A reliable predictor of tumor growth rate?
- (2016) Michael Sommerauer et al. NEURO-ONCOLOGY
- Somatostatin-receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to68Ga-DOTATATE/-TOC uptake
- (2016) Katharina Seystahl et al. NEURO-ONCOLOGY
- 90Y-DOTATOC as a Therapeutic Option for Complex Recurrent or Progressive Meningiomas
- (2015) K. Gerster-Gillieron et al. JOURNAL OF NUCLEAR MEDICINE
- Somatostatin Receptor-Targeted Radiopeptide Therapy with 90Y-DOTATOC and 177Lu-DOTATOC in Progressive Meningioma: Long-Term Results of a Phase II Clinical Trial
- (2015) N. Marincek et al. JOURNAL OF NUCLEAR MEDICINE
- Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review
- (2014) T. Kaley et al. NEURO-ONCOLOGY
- Meningiomas: A Comparative Study of 68Ga-DOTATOC, 68Ga-DOTANOC and 68Ga-DOTATATE for Molecular Imaging in Mice
- (2014) María Luisa Soto-Montenegro et al. PLoS One
- Individualized Dosimetry of Kidney and Bone Marrow in Patients Undergoing 177Lu-DOTA-Octreotate Treatment
- (2012) M. Sandstrom et al. JOURNAL OF NUCLEAR MEDICINE
- Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma
- (2012) Michael C Kreissl et al. Radiation Oncology
- Successful radiopeptide targeting of metastatic anaplastic meningioma: Case report
- (2011) Amir Sabet et al. Radiation Oncology
- Peptide receptor radionuclide therapy with 90Y-DOTATOC in recurrent meningioma
- (2009) Mirco Bartolomei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search